BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1459 related articles for article (PubMed ID: 26605438)

  • 1. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
    Nguyen KT; Zhao Y
    Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo targeted delivery of nanoparticles for theranosis.
    Koo H; Huh MS; Sun IC; Yuk SH; Choi K; Kim K; Kwon IC
    Acc Chem Res; 2011 Oct; 44(10):1018-28. PubMed ID: 21851104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
    Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
    ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles.
    Baek S; Singh RK; Khanal D; Patel KD; Lee EJ; Leong KW; Chrzanowski W; Kim HW
    Nanoscale; 2015 Sep; 7(34):14191-216. PubMed ID: 26260245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional nanoparticles for use in theranostic applications.
    Cole JT; Holland NB
    Drug Deliv Transl Res; 2015 Jun; 5(3):295-309. PubMed ID: 25787729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "One-Pot" Fabrication of Highly Versatile and Biocompatible Poly(vinyl alcohol)-porphyrin-based Nanotheranostics.
    Luo Y; Wu H; Feng C; Xiao K; Yang X; Liu Q; Lin TY; Zhang H; Walton JH; Ajena Y; Hu Y; Lam KS; Li Y
    Theranostics; 2017; 7(16):3901-3914. PubMed ID: 29109786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering Persistent Luminescence Nanoparticles for Biological Applications: From Biosensing/Bioimaging to Theranostics.
    Sun SK; Wang HF; Yan XP
    Acc Chem Res; 2018 May; 51(5):1131-1143. PubMed ID: 29664602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid Decorated Core@Shell Janus Nanoparticles as a Flexible Platform for Targeted Multimodal Molecular Bioimaging of Cancer.
    Sánchez A; Ovejero Paredes K; Ruiz-Cabello J; Martínez-Ruíz P; Pingarrón JM; Villalonga R; Filice M
    ACS Appl Mater Interfaces; 2018 Sep; 10(37):31032-31043. PubMed ID: 30141615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in theranostic applications of hybrid gold nanoparticles.
    Gharatape A; Salehi R
    Eur J Med Chem; 2017 Sep; 138():221-233. PubMed ID: 28668475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoactivated drug delivery and bioimaging.
    Yang Y; Mu J; Xing B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27094696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-infrared light-responsive nanomaterials for cancer theranostics.
    Kim H; Chung K; Lee S; Kim DH; Lee H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(1):23-45. PubMed ID: 25903643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine.
    Ambrogio MW; Thomas CR; Zhao YL; Zink JI; Stoddart JF
    Acc Chem Res; 2011 Oct; 44(10):903-13. PubMed ID: 21675720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand Chemistry in Antitumor Theranostic Nanoparticles.
    Lin G; Zhang M
    Acc Chem Res; 2023 Jun; 56(12):1578-1590. PubMed ID: 37220248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
    Sharma R; Mody N; Agrawal U; Vyas SP
    Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
    Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
    Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic polymeric nanoparticles for NIR imaging and photodynamic therapy.
    Sarcan ET; Silindir-Gunay M; Ozer AY
    Int J Pharm; 2018 Nov; 551(1-2):329-338. PubMed ID: 30244148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy.
    Tassa C; Shaw SY; Weissleder R
    Acc Chem Res; 2011 Oct; 44(10):842-52. PubMed ID: 21661727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapy.
    Hu Y; Mignani S; Majoral JP; Shen M; Shi X
    Chem Soc Rev; 2018 Mar; 47(5):1874-1900. PubMed ID: 29376542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.